Complex Regional Pain Syndrome (CRPS)

Welcome to Vrije Universiteit Brussel's Evidence-based Practice project. This space was created by and for the students in the Rehabilitation Sciences and Physiotherapy program of the Vrije Universiteit Brussel, Brussels, Belgium. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors - Yves Hubar

Lead Editors - Your name will be added here if you are a lead editor on this page.  Read more.

Search Strategy

Literature was found on pubmed and the vub v-spaces system.

Definition/Description

The international association for the study of pain defines CRPS as a collection of locally occurring painful conditions, usually following traumatic injury, which tends to express itself distally and exceeds the expected pain of the original trauma and usually results in significant motor deficit.

CRPS is subdivided into type I and type II CRPS.
Type I CRPS signifies that no peripheral nerve injury can be linked to the condition, while type II signifies that the condition results from a peripheral nerve injury.

Clinically Relevant Anatomy

CRPS can take place in any body part, but the wrist is most frequently affected after fractures.

An important aspect of the disease is the occurance of vascular disturbances. Mostly affected are primary small vessels, causing an impact on microcirculation, skin temperature and clinical appearance of the limb.
A paper described the changes in microcirculation as an increase in the number of capillaries, endothelial swelling and changes in the vessel luminal wall.
According to a review, the acute stage features inhibited sympathetic vasoconstriction and exaggerated neurogenic inflammation, whereas the cold stage features vasoconstriction and endothelial disfunction or vascular hyperreactivity while neurogenic inflammation is less severe.

Epidemiology /Etiology

CRPS is found to result:
- After traumatic injury (65%)
* 1-2% of all fractures result in CRPS
* Largest risk of CRPS for fractures of the wrist
- After surgical intervention (19%)
- Infection (4%)
- Prior inflammation (2%)
- No clear cause (10%)

A review stated that women are predominantly affected, by a factor of 3,5 and a genetic predisposition has also been theorized.
The disease affects all ages, but most cases are between 50 and 70 years old, and is generally believed to occur mainly in caucasian and Japanese people.

Characteristics/Clinical Presentation

The following symptoms have been found in literature:
- Autonomic and trophic disorders:

• Distal Edema in 80% of the patients
• Skin temperature changes at the affected body part in 80% of the patients, initially warmer and in 40% of patients gradually cools down until colder in comparison to the rest of the body as the disease progresses. Another review mentioned that 30% of the patients start off from the primarily cold stage.3
• In 40% of the patients skin at the affected body part starts showing redness, but becomes pale or livid in later stages
• In 55% altered sweating takes place, with hyperhydrosis being more common than hypohydrosis.
• Hair and nail growth possibly increase in early stages
• Atrophy of skin and muscles in later stages, as well as contractures may severely restrict movement

- Sensory disturbances (90%) typically in a glove or stocking-like distribution

• Spontaneous pain occurs in 75%, usually burning dragging or stinging

• 68% felt in deep structures
• 32% felt in skin
• In 77% pain shows fluctuating intensity, lesser proportion shows shooting pain
• Pain can be increased by orthostasis, anxiety, exercise or temperature changes.
• In many cases, pain is more pronounced at night

• Sensory gain (Mechanical hyperalgesia, allodynia, ...) or sensory loss (hypaesthesia, hypalgesia, …) may be present.

- Motor dysfunction

• Motor weakness
• Severe impairment of complex movements
• Impairment of range of motion, initially by concomitant edema, later by contractures and fibroses
• Neglect like symptoms have been found in some patiënts, described as the body part in question feeling foreign.
• Enhanced physiological tremor in around 50%
• Myoclonus or dystonia, especially in type II CRPS
  

Differential Diagnosis

The differential diagnostic consists of:

• Rheumatic conditions
• Inflammatory conditions (infections following bone surgery, neuritides)
• Thromboembolic conditions
• Compartment syndrome
  
• Peripheral neuropathy (mainly for type II CRPS)

Diagnostic Procedures

add text here related to medical diagnostic procedures

Outcome Measures

add links to outcome measures here (also see Outcome Measures Database)

Examination

No golden standard has been developed yet, but included here are the Budapest criteria.

The following must be met
- Continuing pain, which is disproportionate to any inciting event
- Must report at least one symptom in three of the four following categories:

• Sensory: reports of hypaesthesia and/or allodynia
• Vasomotor: reports of temperature asymmetry and/or skin color changes and/or skin color asymmetry
• Sudomotor/edema: reports of edema and/or sweating changes and/or sweating asymmetry
  
• Motor/trophic: reports of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin)

- Must display at least one sign at time of evaluation in two or
more of the following categories:

• Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or temperature sensation and/or deep somatic pressure and/or joint movement)
• Vasomotor: evidence of temperature asymmetry (>1°C) and/or skin color changes and/or asymmetry
• Sudomotor/edema: evidence of edema and/or sweating changes and/or sweating asymmetry
• Motor/trophic: evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin)

- There is no other diagnosis that better explains the signs and symptoms

Medical Management

Pathophysiologically oriented pharmacogenic treatment include application of glucocorticoids, tnf-alpha antibodies, free radical scavengers and sympathic blockade.
Symptomatically oriented pharmacogens include opioids, gabapentin, NSAIDs and baclofen.
To inhibit osteoclastic activity calcitonin, bisphosphonates and mannitol and vasodilating drugs may be given.

Definite reports on the efficacy of sympathectomy are currently lacking and there is a risk of developing post sympathectomy pain syndrome.

A review has been found, describing the positive effects of Spinal Cord Stimulation and several theories regarding its effectiveness.

Physical Therapy Management

add text here

Key Research

add links and reviews of high quality evidence here (case studies should be added on new pages using the case study template)

Resources

add appropriate resources here

Clinical Bottom Line

add text here

Recent Related Research (from Pubmed)

see tutorial on Adding PubMed Feed

References

see adding references tutorial.